A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera

A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera

Introduction:Ruxolitinib is a small -molecule inhibitor of the JAK1/2 pathway. This study aimed to reveal the results and side-effect profile of the use of ruxolitinib as a treatment option in polycythemia vera (PV).Methods:A total of 34 patients with PV from 18 different centers were included in th...

Full description

Bibliographic Details
Main Authors: İstemi Serin, Mehmet Hilmi Doğu, Ömer Ekinci, Gülsüm Akgün Çağlıyan, Abdulkadir Baştürk, Merih Reis Aras, Sinan Demircioğlu, Burhan Turgut, Mustafa Merter, Sibel Kabukçu Hacıoğlu, Metin Bağcı, Murat Albayrak, Serdal Korkmaz, Mehmet Ali Erkurt, Mehmet Sinan Dal, Fadime Ersoy Dursun, Anıl Tombak, İsmet Aydoğdu, Turgay Ulaş, Fevzi Altuntaş
Format: Article
Language:English
Published: Galenos Yayinevi 2023-05-01
Series:İstanbul Medical Journal
Subjects:
polycythemia vera
ruxolitinib
real-life data
response
side effect
Online Access: http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/a-real-life-turkish-experience-of-ruxolitinib-in-p/60509

Internet

http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/a-real-life-turkish-experience-of-ruxolitinib-in-p/60509

Similar Items